Physician profile
Robert Gordon Graper
NPI 1043346570
$13,321.42
in general payments reported to CMS, 2019-2025
17 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $335 · 2021: $3,175 · 2022: $5,667 · 2023: $1,131 · 2024: $1,368 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,104 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,103.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $446.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $8,852.55 | 2019-2022 | |
| Abbvie INC. | $2,437.00 | 2023-2025 | |
| Mentor Worldwide LLC | $532.24 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Musculoskeletal Transplant Foundation INC. | $486.03 | 2019-2025 | |
| Motiva USA, LLC | $175.94 | 2025 | |
| Tepha INC | $111.37 | 2019 | |
| Davol INC. | $109.55 | 2022 | |
| Integra Lifesciences Corporation | $104.87 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Heron Therapeutics, INC. | $101.57 | 2025 | Zynrelef |
| Acelrx Pharmaceuticals, INC. | $71.81 | 2019-2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $67.97 | 2022-2025 | |
| Baxter Healthcare | $67.86 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $61.24 | 2022-2023 | Seglentis |
| Biotissue Holdings INC. | $60.81 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $31.05 | 2025 | Exparel |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $29.46 | 2019-2020 | |
| Convatec INC. | $20.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Graper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.